LACTOSE (INDIA) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.2 INR | +4.90% |
|
+0.94% | +10.96% |
| Sales 2022 | 459M 5.51M 7.53M | Sales 2023 | 658M 7.89M 10.79M | Capitalization | 554M 6.64M 9.08M |
|---|---|---|---|---|---|
| Net income 2022 | 24M 288K 394K | Net income 2023 | 12M 144K 197K | EV / Sales 2022 | 2.5 x |
| Net Debt 2022 | 394M 4.73M 6.46M | Net Debt 2023 | 384M 4.6M 6.29M | EV / Sales 2023 | 1.42 x |
| P/E ratio 2022 |
28.6
x | P/E ratio 2023 |
45.8
x | Employees | 109 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.03% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.90% | ||
| 1 week | +0.94% | ||
| Current month | -10.97% | ||
| 1 month | -13.02% | ||
| 3 months | -7.20% | ||
| 6 months | +44.23% | ||
| Current year | +10.96% |
1 week
132.00
144.45
1 month
132.00165.55
Current year
107.80173.65
1 year
40.20173.65
3 years
28.30173.65
5 years
14.35173.65
10 years
11.02190.05
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | 57 | 14-01-23 | |
Ritesh Pandey
CMP | Compliance Officer | 37 | 20-01-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Atul Maheshwari
BRD | Director/Board Member | 58 | 91-03-10 |
G. K. Sarda
BRD | Director/Board Member | 75 | 08-10-08 |
| Director/Board Member | 65 | 22-03-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 139.2 | +4.90% | 9 011 |
| 24-05-28 | 132.8 | -3.87% | 4,932 |
| 24-05-27 | 138.1 | -1.53% | 4,658 |
| 24-05-24 | 140.2 | +0.25% | 5,229 |
| 24-05-23 | 139.9 | +1.41% | 9,972 |
Delayed Quote Bombay S.E., May 29, 2024 at 06:00 am
More quotes
Lactose (India) Limited is an India-based pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company is principally engaged in the manufacturing of lactose monohydrate. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It manufactures disaccharide lactulose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic. It also manufactures dry granulated, film and lacquer coated tablets. The Company is also engaged in exporting uncoated and blister packed solid dose forms. The Company's plant is located at Taluka Savli, Vadodara, Gujarat. Its lactose manufacturing facility has a capacity of 10000 metric tons/annum with an average capacity of 30 metric tons/ day.
Sector
Food Processing
Calendar
2024-05-29
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +10.96% | 20.09M | |
| -5.96% | 264B | |
| -6.71% | 90.64B | |
| -5.22% | 42.56B | |
| +0.24% | 41.13B | |
| +5.99% | 39.96B | |
| +2.36% | 37.64B | |
| -15.69% | 30.11B | |
| -7.19% | 28.41B | |
| +12.46% | 25.17B |
- Stock Market
- Equities
- LACTOSE6 Stock
